Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: preceding (28), earlier (169), prior (757)

AmB-(TICE)-Carboplatin-Etoposide

Description: Chemotherapy Protocol GERM CELL Amb TICE (Part 2): Carboplatin – Etoposide phosphate Ambulatory Regimen This regimen
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Germcell/AmB-TICE-Carboplatin-Etoposide.pdf

Pre-eclampsia - patient information

Description: This factsheet explains what pre-eclampsia is, what causes it, and the steps you and your maternity team can take to
Url: /Media/UHS-website-2019/Patientinformation/Pregnancyandbirth/Pre-eclampsia-4046-PIL.pdf

Functional magnetic resonance imaging (MRI) brain scan - patient information

Description: This factsheet explains what a functional magnetic resonance imaging (MRI) brain scan is and what to expect at your appointment.
Url: /Media/UHS-website-2019/Patientinformation/Scansandx-rays/Functional-magnetic-resonance-imaging-MRI-brain-scan-4021-PIL.pdf

Lower lid entropion - patient information

Description: This factsheet explains what lower lid entropion is and how it is treated.
Url: /Media/UHS-website-2019/Patientinformation/Eyes/Lower-lid-entropion-1910-PIL.pdf

AmB-LISOCEL-Cyclophosphamide (300)-Fludarabine (30)

Description: Chemotherapy Protocol CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY AmB – LISOCEL – CYCLOPHOSPHAMIDE (300) – FLUDARABINE (30) Ambulatory Regimen T
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/AmB-LISOCEL-Cyclophosphamide-300-Fludarabine-30.pdf

2025 WRES report and action plan

Description: Workforce Race Equality Standard Annual Report 2025 1 Executive Summary WRES Data has been submitted by the
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Equality-reports/2025-wres-report-and-action-plan.pdf

Belantamab Bortezomib Dexamethasone Weekly

Description: Chemotherapy Protocol BELANTAMAB MAFODOTIN – BORTEZOMIB - DEXAMETHASONE This protocol may require funding Regimen • Belantamab Mafodotin – Bortezomib - Dexamethasone Indication • 1 previous line of
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/Belantamab-Bortezomib-Dexamethasone-Weekly-Ver1.pdf

Epilepsy: information for parents and guardians - patient information

Description: This factsheet explains what epilepsy is and how you can live well with epilepsy.
Url: /Media/UHS-website-2019/Patientinformation/Childhealth/Epilepsy-information-for-parents-and-guardians-2177-PIL.pdf

Finance, Investment and Cash Committee ToR October 2025

Description: Finance, Investment and Cash Committee Terms of Reference Date Issued: Review Date: Document Type: 7 October 2025 October
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2025-Trust-documents/Finance-Investment-and-Cash-Committee-ToR-October-2025.pdf

Surgery for severe endometriosis - patient information

Description: This factsheet explains what endometriosis is, what the surgery for severe endometriosis involves and the possible risks of having the surgery
Url: /Media/UHS-website-2019/Patientinformation/Womenshealth/Surgery-for-severe-endometriosis-2261-PIL.pdf

351 to 360 of 489

Previous … 34 35 36 37 38 … Next